Suppr超能文献

扁平部玻璃体切除术后脉络膜上腔出血:10 年的风险因素和结果。

Suprachoroidal hemorrhage in pars plana vitrectomy: risk factors and outcomes over 10 years.

机构信息

Vitreoretinal Department, Moorfields Eye Hospital, London, United Kingdom; Research & Development, Moorfields Eye Hospital, London, United Kingdom.

Research & Development, Moorfields Eye Hospital, London, United Kingdom.

出版信息

Ophthalmology. 2014 Jan;121(1):311-317. doi: 10.1016/j.ophtha.2013.06.021. Epub 2013 Jul 18.

Abstract

PURPOSE

To investigate the rate and risk factors of developing suprachoroidal hemorrhage (SCH) after pars plana vitrectomy (PPV) and the outcomes as a result.

DESIGN

Retrospective, comparative consecutive series.

PARTICIPANTS

A total of 5459 patients who underwent pars plana vitrectomies over 10 years in 3 surgical centers.

METHODS

All patient demographic, medical, and ophthalmic data and operative information from 3 vitreoretinal centers were entered prospectively into an electronic medical record. Univariate analysis was undertaken, comparing risk factors between cases (SCH) and controls. Multivariable logistic regression was performed to test for independence between the risk factors (P < 0.2 in univariate analysis) and SCH.

MAIN OUTCOME MEASURES

Risk factors for developing SCH. Visual outcome and development of complications.

RESULTS

A total of 5459 PPVs were undertaken for a wide range of indications. Fifty-six cases of PPV were complicated by SCH (1.03%). Multivariable logistic regression showed that significant risk factors for developing this included advancing age, (mean age, 69 years in cases and 60 years in controls; odds ratio [OR], 1.04; P = 0.001), male sex (76.8% of cases and 58.7% of controls; OR, 2.38; P = 0.008), presence of rhegmatogenous retinal detachment (RRD) (80.3% of cases and 52.5% of controls; OR, 5.92; P < 0.0001), presence of a dropped lens fragment (10.7% of cases and 4.5% of controls; OR, 6.94; P = 0.002), and the use of antiplatelet or anticoagulant drugs (33.9% of cases and 17.7% of controls; OR, 2.29; P = 0.007). Suprachoroidal hemorrhage was more common with increasing quadrants of RRD. The significant operative risk factor was application of an explant (25% of cases and 4.07% of controls; OR, 5.63; P < 0.0001). Phthisis (7.1% of cases and 0.9% of controls; P = 0.002, Fisher exact test) and glaucoma (14.3% of cases and 7.2% of controls; P = 0.044, chi-square test) were more common in cases than in controls.

CONCLUSIONS

The risk factors for developing intraoperative SCH during PPV are male sex, advancing age, RRD, a scleral explant, a dropped lens fragment, and the use of aspirin or warfarin. Patients with this complication have a greater risk of developing ocular hypertension requiring treatment and phthisis.

摘要

目的

研究接受玻璃体切除术(PPV)后发生脉络膜上腔出血(SCH)的发生率和风险因素,以及由此导致的结果。

设计

回顾性、对照性连续系列研究。

参与者

在 3 家外科中心进行玻璃体切除术的 5459 例患者。

方法

从 3 家玻璃体视网膜中心前瞻性地输入所有患者的人口统计学、医学和眼科数据以及手术信息。对病例(SCH)和对照组之间的风险因素进行单变量分析比较。多变量逻辑回归用于测试风险因素(单变量分析中 P<0.2)与 SCH 之间的独立性。

主要观察指标

发生 SCH 的风险因素。视力结果和并发症的发展。

结果

共进行了 5459 例 PPV,适应证广泛。56 例 PPV 并发 SCH(1.03%)。多变量逻辑回归显示,发生这种情况的显著风险因素包括年龄增长(病例组平均年龄为 69 岁,对照组为 60 岁;优势比[OR],1.04;P=0.001)、男性(病例组为 76.8%,对照组为 58.7%;OR,2.38;P=0.008)、存在孔源性视网膜脱离(RRD)(病例组为 80.3%,对照组为 52.5%;OR,5.92;P<0.0001)、存在脱落的晶状体碎片(病例组为 10.7%,对照组为 4.5%;OR,6.94;P=0.002)和使用抗血小板或抗凝药物(病例组为 33.9%,对照组为 17.7%;OR,2.29;P=0.007)。RRD 的象限越多,脉络膜上腔出血越常见。显著的手术风险因素是应用巩膜植入物(病例组为 25%,对照组为 4.07%;OR,5.63;P<0.0001)。病例组的眼球萎缩(7.1%)和青光眼(14.3%)比对照组更常见(病例组为 0.9%;P=0.002,Fisher 确切检验;P=0.044,卡方检验)。

结论

接受 PPV 时发生术中 SCH 的风险因素包括男性、年龄增长、RRD、巩膜植入物、脱落的晶状体碎片和使用阿司匹林或华法林。发生这种并发症的患者更有可能出现需要治疗的眼内压升高和眼球萎缩。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验